l-methylfolate calcium + lidocaine + prilocaine + pyridoxine + capsaicin

This is a **combination product** consisting of l-methylfolate calcium (an active form of folate), lidocaine (a local anesthetic), prilocaine (a local anesthetic), pyridoxine (vitamin B6), and capsaicin (a topical analgesic). The combination is likely intended for the management of neuropathic pain or similar pain syndromes, leveraging l-methylfolate and pyridoxine's roles in nerve health, lidocaine/prilocaine's ability to block voltage-gated sodium channels and provide local anesthesia, and capsaicin's mechanism as a TRPV1 receptor agonist resulting in pain desensitization. Each component is approved individually for various indications: - **Lidocaine/prilocaine** (often as a eutectic topical cream) are used for local anesthesia by blocking nerve signal conduction via inhibition of sodium channels. - **Capsaicin** is approved for symptomatic relief of neuropathic pain and acts by inducing desensitization of sensory neurons through repeated activation of TRPV1 receptors. - **Pyridoxine** is indicated for vitamin B6 deficiency and, in higher doses, is also used for certain types of neuropathy and as a co-factor in nervous system function. - **L-methylfolate calcium** is a bioavailable form of folate often used in supplements and possibly formulations targeting neuropathic symptoms or folate deficiency. This precise combination does not align with any known branded or FDA/EMA-approved medication but could be available as a compounded product, likely aimed at synergistic pain relief, especially in neuropathic pain.